Vitamin D status during pregnancy and in cord blood in a large prospective French cohort.


Journal

Clinical nutrition (Edinburgh, Scotland)
ISSN: 1532-1983
Titre abrégé: Clin Nutr
Pays: England
ID NLM: 8309603

Informations de publication

Date de publication:
10 2019
Historique:
received: 13 03 2018
revised: 20 08 2018
accepted: 27 08 2018
pubmed: 19 9 2018
medline: 9 9 2020
entrez: 19 9 2018
Statut: ppublish

Résumé

Vitamin D status during pregnancy and in newborns has never been studied in France. This study aims at determining the vitamin D status during the first and third trimesters of pregnancy (T1, T3) and in cord blood (CB) in the middle-north of France. We conducted a prospective cohort study in five French centers (latitude 47.22 to 48.86°N). Serum 25(OH)-vitamin D (25(OH)D) concentrations were measured using a radioimmunoassay during T1, T3 and in CB. According to the French guidelines, pregnant women received cholecalciferol, 100,000 IU, in the seventh month. Between April 2012 and July 2014, 2832 women were included, of whom 2803 were analyzed (mean ± SD age: 31.5 ± 5.0 years; phototypes 5-6: 21.8%). Three and 88.6% of participants received supplementation during the month before inclusion and in the seventh month, respectively. At T1, T3, and CB, mean 25(OH)D concentrations were 21.9 ± 10.4, 31.8 ± 11.5, and 17.0 ± 7.2 ng/mL, respectively, and 25(OH)D was <20 ng/mL in 46.5%, 14.0%, and 68.5%, respectively. At T1, body mass index ≥25 kg/m Despite the recommended supplementation, vitamin D insufficiency is frequent during pregnancy and in newborns in France.

Sections du résumé

BACKGROUND & AIMS
Vitamin D status during pregnancy and in newborns has never been studied in France. This study aims at determining the vitamin D status during the first and third trimesters of pregnancy (T1, T3) and in cord blood (CB) in the middle-north of France.
METHODS
We conducted a prospective cohort study in five French centers (latitude 47.22 to 48.86°N). Serum 25(OH)-vitamin D (25(OH)D) concentrations were measured using a radioimmunoassay during T1, T3 and in CB. According to the French guidelines, pregnant women received cholecalciferol, 100,000 IU, in the seventh month.
RESULTS
Between April 2012 and July 2014, 2832 women were included, of whom 2803 were analyzed (mean ± SD age: 31.5 ± 5.0 years; phototypes 5-6: 21.8%). Three and 88.6% of participants received supplementation during the month before inclusion and in the seventh month, respectively. At T1, T3, and CB, mean 25(OH)D concentrations were 21.9 ± 10.4, 31.8 ± 11.5, and 17.0 ± 7.2 ng/mL, respectively, and 25(OH)D was <20 ng/mL in 46.5%, 14.0%, and 68.5%, respectively. At T1, body mass index ≥25 kg/m
CONCLUSIONS
Despite the recommended supplementation, vitamin D insufficiency is frequent during pregnancy and in newborns in France.

Identifiants

pubmed: 30224306
pii: S0261-5614(18)32429-4
doi: 10.1016/j.clnu.2018.08.035
pii:
doi:

Substances chimiques

Vitamin D 1406-16-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2136-2144

Informations de copyright

Copyright © 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Auteurs

Marie Courbebaisse (M)

Department of Physiology, Georges Pompidou European Hospital, AP-HP, Université Paris Descartes, INSERM U1151-CNRS UMR8253, Paris, France. Electronic address: marie.courbebaisse@aphp.fr.

Jean-Claude Souberbielle (JC)

Department of Physiology, Necker-Enfants Malades Hospital, AP-HP, Paris, France.

Amandine Baptiste (A)

URC/CIC Paris Descartes Necker Cochin, Necker-Enfants Malades Hospital, AP-HP, Paris, France.

Joëlle Taieb (J)

Department of Biochemistry, Antoine-Béclère Hospital, AP-HP, Université Paris-Sud, Clamart, France.

Vassilis Tsatsaris (V)

Fondation PremUp, Paris, France; Department of Obstetrics, Cochin Hospital, AP-HP, Université René Descartes, Paris, France.

Jean Guibourdenche (J)

Department of Hormonal Biochemistry, Cochin Hospital, AP-HP, Université René Descartes, Paris, France.

Marie-Victoire Senat (MV)

Department of Obstetrics and Gynecology, Bicêtre Hospital, AP-HP, Université Paris-Sud, Kremlin Bicêtre, France.

Hazar Haidar (H)

Department of Molecular Genetics, Pharmacogenetics and Hormonology, Bicêtre Hospital, AP-HP, Université Paris-Sud, Kremlin Bicêtre, France.

Jacques Jani (J)

Department of Obstetrics and Gynecology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium.

Meriem Guizani (M)

Department of Obstetrics and Gynecology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium.

Jean-Marie Jouannic (JM)

Fetal Medicine Department, Armand Trousseau Hospital, UPMC-Sorbonne Université, Paris, France.

Marie-Clotilde Haguet (MC)

Department of Biochemistry, Armand Trousseau Hospital, UPMC-Sorbonne Université, Paris, France.

Norbert Winer (N)

Department of Obstetrics and Gynecology, Nantes University Hospital, 44000, France.

Damien Masson (D)

Department of Biochemistry, Nantes University Hospital Hôtel-Dieu, Nantes, 44000, France.

Caroline Elie (C)

URC/CIC Paris Descartes Necker Cochin, Necker-Enfants Malades Hospital, AP-HP, Paris, France.

Alexandra Benachi (A)

Fondation PremUp, Paris, France; Department of Obstetrics and Gynecology, Antoine-Béclère Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris-Sud, Clamart, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH